Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 10.37 is 27% above its 5-year average of 8.14, around the middle of its 5-year range (4.37–18.31).
As of the fiscal period ended Tuesday, June 30, 2026. 43.82% above its 12-month average of 7.21.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 10.37.
QUICK RATIO (ACID-TEST)
10.37
QUICK RATIO (ACID-TEST) AVG TTM
7.21
QUICK RATIO (ACID-TEST) AVG 3Y
7.34
QUICK RATIO (ACID-TEST) AVG 5Y
8.14
QUICK RATIO (ACID-TEST) AVG 10Y
7.20
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+43.82%
CURRENT VS 3Y AVG
+41.21%
CURRENT VS 5Y AVG
+27.34%
CURRENT VS 10Y AVG
+43.96%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 871 covered companies
CURRENT VS SECTOR MEDIAN
+209.48%
vs the sector median at left
Sol-Gel Technologies Ltd.
Market Cap
$247.27M
Quick Ratio (Acid-Test)
10.37
TTM Avg
7.21
3Y Avg
7.34
5Y Avg
8.14
Market Cap
$247.62M
Quick Ratio (Acid-Test)
0.10
TTM Avg
1.46
3Y Avg
1.56
5Y Avg
2.73
Market Cap
$248.50M
Quick Ratio (Acid-Test)
4.70
TTM Avg
7.13
3Y Avg
7.51
5Y Avg
5.59
Market Cap
$249.79M
Quick Ratio (Acid-Test)
27.99
TTM Avg
35.39
3Y Avg
23.13
5Y Avg
23.13
Market Cap
$241.94M
Quick Ratio (Acid-Test)
2.69
TTM Avg
2.01
3Y Avg
1.61
5Y Avg
1.29
Market Cap
$241.39M
Quick Ratio (Acid-Test)
20.30
TTM Avg
4.91
3Y Avg
4.89
5Y Avg
6.73
Market Cap
$241.34M
Quick Ratio (Acid-Test)
9.97
TTM Avg
9.63
3Y Avg
16.17
5Y Avg
19.97
Market Cap
$239.02M
Quick Ratio (Acid-Test)
8.28
TTM Avg
3.73
3Y Avg
7.03
5Y Avg
8.20
Market Cap
$239.01M
Quick Ratio (Acid-Test)
0.81
TTM Avg
0.81
3Y Avg
0.76
5Y Avg
0.71
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Sol-Gel Technologies Ltd. (SLGL) | $247.27M | 10.37 | 7.21 | 7.34 | 8.14 |
| Galectin Therapeutics Inc. (GALT)vs › | $247.62M | 0.10 | 1.46 | 1.56 | 2.73 |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $248.50M | 4.70 | 7.13 | 7.51 | 5.59 |
| Upstream Bio, Inc. (UPB)vs › | $249.79M | 27.99 | 35.39 | 23.13 | 23.13 |
| Lifecore Biomedical, Inc. (LFCR)vs › | $241.94M | 2.69 | 2.01 | 1.61 | 1.29 |
| Q32 Bio Inc. (QTTB)vs › | $241.39M | 20.30 | 4.91 | 4.89 | 6.73 |
| Quantum-Si incorporated (QSI)vs › | $241.34M | 9.97 | 9.63 | 16.17 | 19.97 |
| Century Therapeutics, Inc. (IPSC)vs › | $239.02M | 8.28 | 3.73 | 7.03 | 8.20 |
| High Tide Inc. (HITI)vs › | $239.01M | 0.81 | 0.81 | 0.76 | 0.71 |
| Anika Therapeutics, Inc. (ANIK)vs › | $255.88M | 3.19 | 3.85 | 4.21 | 4.14 |
Quick Ratio
10.37
Excludes inventory
Current Ratio
10.37
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 10.37 |
| 2026-03-31 | 8.84 |
| 2025-12-31 | 4.37 |
| 2025-09-30 | 5.15 |
| 2025-06-30 | 7.32 |
| 2025-03-31 | 5.12 |
| 2024-12-31 | 5.92 |
| 2024-09-30 | 5.81 |
| 2024-06-30 | 7.36 |
| 2024-03-31 | 6.89 |
| 2023-12-31 | 9.10 |
| 2023-09-30 | 10.09 |
| 2023-06-30 | 9.10 |
| 2023-03-31 | 10.37 |
| 2022-12-31 | 12.93 |
| 2022-09-30 | 18.31 |
| 2022-06-30 | 15.03 |
| 2022-03-31 | 11.09 |
| 2021-12-31 | 4.88 |
| 2021-09-30 | 5.05 |
| 2021-06-30 | 8.03 |
| 2021-03-31 | 10.83 |
| 2020-12-31 | 8.95 |
| 2020-09-30 | 8.55 |
| 2020-06-30 | 9.94 |
| 2020-03-31 | 9.51 |
| 2019-12-31 | 8.58 |
| 2019-09-30 | 7.80 |
| 2019-06-30 | 8.00 |
| 2019-03-31 | 8.29 |
| 2018-12-31 | 13.48 |
| 2018-09-30 | 15.96 |
| 2018-06-30 | 20.77 |
| 2018-03-31 | 43.20 |
| 2017-12-31 | 0.16 |
| 2017-09-30 | 0.25 |
| 2017-06-30 | 0.35 |
| 2017-03-31 | 0.00 |
| 2016-12-31 | 0.20 |
| 2016-09-30 | 0.00 |
| 2016-06-30 | 0.00 |
| 2016-03-31 | 0.00 |
